Research output per year
Research output per year
Fingerprint
Dive into the research topics where Junyong Park is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis
Kim, M. N., Lee, J. S., Lee, H. W., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Jang, S. Y., Tak, W. Y., Kweon, Y. O., Park, S. Y. & Kim, S. U., 2023, (Accepted/In press) In: Clinical Gastroenterology and Hepatology.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Erratum to ‘Identification of a distinct NK-like hepatic T-cell population activated by NKG2C in a TCR-independent manner’ [J Hepatol 77 (2022) 1059-1070, (S016882782200335X), (10.1016/j.jhep.2022.05.020)]
Koh, J. Y., Rha, M. S., Choi, S. J., Lee, H. S., Han, J. W., Nam, H., Kim, D. U., Lee, J. G., Kim, M. S., Park, J. Y., Park, S. H., Joo, D. J. & Shin, E. C., 2023 Feb, In: Journal of Hepatology. 78, 2, p. 450-451 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
Lee, H. S., Han, D. H., Cho, K., Park, S. B., Kim, C., Leem, G., Jung, D. E., Kwon, S. S., Kim, C. H., Jo, J. H., Lee, H. W., Song, S. Y. & Park, J. Y., 2023 Dec, In: Nature communications. 14, 1, 237.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease
Chun, H. S., Lee, M., Lee, J. S., Lee, H. W., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Lee, Y. H., Kim, J. H. & Kim, S. U., 2023 Mar, In: Liver International. 43, 3, p. 608-625 18 p.Research output: Contribution to journal › Article › peer-review
-
Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma
Kim, Y., Lee, J. S., Lee, H. W., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Goh, M. J., Kang, W. & Kim, S. U., 2023 Feb 1, In: European Journal of Gastroenterology and Hepatology. 35, 2, p. 191-197 7 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)
Press/Media
-
Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis
20/11/10
1 item of Media coverage
Press/Media: Press / Media
-
Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) Adults
20/10/26
1 item of Media coverage
Press/Media: Press / Media
-
PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)
18/10/2 → 20/9/12
2 items of Media coverage
Press/Media: Press / Media
-
Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment; RELIF-C
18/10/2
1 item of Media coverage
Press/Media: Press / Media
-
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA
18/10/2
1 item of Media coverage
Press/Media: Press / Media